: The AMEDEO Literature Guide

Home

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

Hepatology 2012 (546 pages, free PDF)
Hepatitis C 2012 (150 pages, free PDF)

Free Medical Books

Prostate Cancer

Free Subscription

Articles published in BJU Int
Retrieve available abstracts of 409 articles:
HTML format
Text format

Single Articles

May 2012

LARKIN SE , Townsend PA
ASSOCIATION OF COMMON VARIATIONS OF 8q24 WITH THE RISK OF PROSTATE CANCER IN KOREANS AND A REVIEW OF THE ASIAN POPULATION.
BJU Int. 2012 May 15. doi: 10.1111/j.1464-410X.2012.11236.
PubMed Text format Related articles

GARCIA-CRUZ E , Piqueras M, Huguet J, Peri L, et al
Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
BJU Int. 2012 May 15. doi: 10.1111/j.1464-410X.2012.11232.
PubMed Text format Related articles Abstract available

JOUNG JY , Park S, Yoon H, Lee SJ, et al
Association of common variations of 8q24 with the risk of prostate cancer in Koreans and a review of the Asian population.
BJU Int. 2012 May 15. doi: 10.1111/j.1464-410X.2012.11211.
PubMed Text format Related articles Abstract available

PANDHA H , Sorensen KD, Orntoft TF, Langley S, et al
Urinary engrailed-2 (EN2) levels predict tumour volume in men undergoing radical prostatectomy for prostate cancer.
BJU Int. 2012 May 15. doi: 10.1111/j.1464-410X.2012.11208.
PubMed Text format Related articles Abstract available

MORGENTALER A
LOW TESTOSTERONE LEVELS ARE RELATED TO POOR PROGNOSIS FACTORS IN MEN WITH PROSTATE CANCER PRIOR TO TREATMENT.
BJU Int. 2012 May 15. doi: 10.1111/j.1464-410X.2012.11243.
PubMed Text format Related articles

BOSSET PO , Albiges L, Seisen T, de la Motte Rouge T, et al
Current role of diethylstilbestrol in the management of advanced prostate cancer.
BJU Int. 2012 May 11. doi: 10.1111/j.1464-410X.2012.11206.
PubMed Text format Related articles Abstract available

MIYAZAKI H , Nishimatsu H, Kume H, Suzuki M, et al
Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel.
BJU Int. 2012 May 11. doi: 10.1111/j.1464-410X.2012.11205.
PubMed Text format Related articles Abstract available

KOUTALELLIS G , Stravodimos K, Avgeris M, Mavridis K, et al
L-dopa decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer.
BJU Int. 2012 May 9. doi: 10.1111/j.1464-410X.2012.11152.
PubMed Text format Related articles Abstract available

STOCK RG , Berkowitz J, Blacksburg SR, Stone NN, et al
Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure.
BJU Int. 2012 May 9. doi: 10.1111/j.1464-410X.2012.11057.
PubMed Text format Related articles Abstract available

SOORIAKUMARAN P , Spahn M, Wiklund P
Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint.
BJU Int. 2012 May 8. doi: 10.1111/j.1464-410X.2012.11201.
PubMed Text format Related articles

MASSON S , Bahl A
Metastatic castrate-resistant prostate cancer: dawn of a new age of management.
BJU Int. 2012 May 7. doi: 10.1111/j.1464-410X.2012.11076.
PubMed Text format Related articles Abstract available

SCIARRA A , Panebianco V, Cattarino S, Busetto G, et al
Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
BJU Int. 2012 May 4. doi: 10.1111/j.1464-410X.2012.11146.
PubMed Text format Related articles Abstract available

IREMASHVILI V , Manoharan M, Rosenberg DL, Soloway MS, et al
Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
BJU Int. 2012 May 4. doi: 10.1111/j.1464-410X.2012.11127.
PubMed Text format Related articles Abstract available

April 2012

WESTOVER K , Chen MH, Moul J, Robertson C, et al
Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer.
BJU Int. 2012 Apr 30. doi: 10.1111/j.1464-410X.2012.11012.
PubMed Text format Related articles Abstract available

FRANLUND M , Carlsson S, Stranne J, Aus G, et al
The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of >/=3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening Trial.
BJU Int. 2012 Apr 30. doi: 10.1111/j.1464-410X.2012.10962.
PubMed Text format Related articles Abstract available

OH JJ , Hong SK, Lee JK, Lee BK, et al
Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
BJU Int. 2012 Apr 30. doi: 10.1111/j.1464-410X.2012.11182.
PubMed Text format Related articles Abstract available

POULSEN MH , Bouchelouche K, Hoilund-Carlsen PF, Petersen H, et al
[(18) F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
BJU Int. 2012 Apr 23. doi: 10.1111/j.1464-410X.2012.11150.
PubMed Text format Related articles Abstract available

POND GR , Armstrong AJ, Wood BA, Leopold L, et al
Ability of C-reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel-based chemotherapy.
BJU Int. 2012 Apr 23. doi: 10.1111/j.1464-410X.2012.11148.
PubMed Text format Related articles Abstract available

BUDAUS L , Isbarn H, Tennstedt P, Salomon G, et al
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patients.
BJU Int. 2012 Apr 23. doi: 10.1111/j.1464-410X.2012.11147.
PubMed Text format Related articles Abstract available

EYLERT MF , Bahl A, Persad R
Do we need to obtain consent for penile shortening as a complication of treatment for organ-confined prostate cancer?
BJU Int. 2012 Apr 23. doi: 10.1111/j.1464-410X.2012.11102.
PubMed Text format Related articles Abstract available

KJOLHEDE H , Ahlgren G, Almquist H, Liedberg F, et al
Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
BJU Int. 2012 Apr 13. doi: 10.1111/j.1464-410X.2012.11123.
PubMed Text format Related articles Abstract available

MOTTET N , Van Damme J, Loulidi S, Russel C, et al
Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial.
BJU Int. 2012 Apr 13. doi: 10.1111/j.1464-410X.2012.11120.
PubMed Text format Related articles Abstract available

CHEN RC , Zhang Y, Chen MH, McMahon E, et al
Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial.
BJU Int. 2012 Apr 13. doi: 10.1111/j.1464-410X.2012.11117.
PubMed Text format Related articles Abstract available

AXCRONA K , Aaltomaa S, da Silva CM, Ozen H, et al
Androgen deprivation therapy for volume reduction, lower urinary tract symptom relief and quality of life improvement in patients with prostate cancer: degarelix vs goserelin plus bicalutamide.
BJU Int. 2012 Apr 13. doi: 10.1111/j.1464-410X.2012.11107.
PubMed Text format Related articles Abstract available

LUGHEZZANI G , Gallina A, Larcher A, Briganti A, et al
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.
BJU Int. 2012 Apr 4. doi: 10.1111/j.1464-410X.2012.11114.
PubMed Text format Related articles Abstract available

GRANT WB
Prostate cancer incidence in australia correlates inversely with solar radiation.
BJU Int. 2012;109 Suppl 3:72-3.
PubMed Text format Related articles

GARDINER RA
Prostate cancer incidence in australia correlates inversely with solar radiation.
BJU Int. 2012;109 Suppl 3:71.
PubMed Text format Related articles

PAN D , McCahy P
Patient knowledge about prostate-specific antigen (PSA) and prostate cancer in Australia.
BJU Int. 2012;109 Suppl 3:52-6.
PubMed Text format Related articles Abstract available

ISCHIA JJ , Pang CY, Tay YK, Li Wai Suen CF, et al
Active surveillance for prostate cancer: an Australian experience.
BJU Int. 2012;109 Suppl 3:40-3.
PubMed Text format Related articles Abstract available

March 2012

SMEENGE M , Barentsz J, Cosgrove D, de la Rosette J, et al
Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel.
BJU Int. 2012 Mar 30. doi: 10.1111/j.1464-410X.2012.11072.
PubMed Text format Related articles Abstract available

PAYNE H , Bahl A, Mason M, Troup J, et al
Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities.
BJU Int. 2012 Mar 19. doi: 10.1111/j.1464-410X.2011.10886.
PubMed Text format Related articles Abstract available

MAGNANI T , Valdagni R, Salvioni R, Villa S, et al
The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes.
BJU Int. 2012 Mar 8. doi: 10.1111/j.1464-410X.2012.10970.
PubMed Text format Related articles Abstract available

KIM HS , Masko EM, Poulton SL, Kennedy KM, et al
Carbohydrate restriction and lactate transporter inhibition in a mouse xenograft model of human prostate cancer.
BJU Int. 2012 Mar 6. doi: 10.1111/j.1464-410X.2012.10971.
PubMed Text format Related articles Abstract available

BAHL A , Bellmunt J, Oudard S
Practical aspects of metastatic castration-resistant prostate cancer management: patient case studies.
BJU Int. 2012;109 Suppl 2:14-9.
PubMed Text format Related articles Abstract available

BELLMUNT J , Attard G, Bahl A, Huland H, et al
Advances in the management of high-risk localised and metastatic prostate cancer.
BJU Int. 2012;109 Suppl 2:8-13.
PubMed Text format Related articles Abstract available

MARBERGER M , Barentsz J, Emberton M, Hugosson J, et al
Novel approaches to improve prostate cancer diagnosis and management in early-stage disease.
BJU Int. 2012;109 Suppl 2:1-7.
PubMed Text format Related articles Abstract available

TOMBAL B
New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist.
BJU Int. 2012;109:E16.
PubMed Text format Related articles

FITZPATRICK JM
Chairman's foreword. Recent advances in prostate cancer management.
BJU Int. 2012;109 Suppl 2:v.
PubMed Text format Related articles Abstract available

EDEN CG , Zacharakis E, Dundee PE, Hutton AC, et al
Incidence of lymphoceles after robot-assisted pelvic lymph node dissection.
BJU Int. 2012;109:E14.
PubMed Text format Related articles

NUMAO N , Kawakami S, Sakura M, Yoshida S, et al
Characteristics and clinical significance of prostate cancers missed by initial transrectal 12-core biopsy.
BJU Int. 2012;109:665-71.
PubMed Text format Related articles Abstract available

SHAO Y , Lu GL, Shen ZJ
Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis.
BJU Int. 2012;109:691-4.
PubMed Text format Related articles Abstract available

CORCORAN NM , Hovens CM, Hong MK, Pedersen J, et al
Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours.
BJU Int. 2012;109:660-4.
PubMed Text format Related articles Abstract available

WILLIS DL , Gonzalgo ML, Brotzman M, Feng Z, et al
Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: a study of comparative effectiveness based upon validated quality of life outcomes.
BJU Int. 2012;109:898-905.
PubMed Text format Related articles Abstract available

DEORAH S , Rao MB, Raman R, Gaitonde K, et al
Survival of patients with small cell carcinoma of the prostate during 1973-2003: a population-based study.
BJU Int. 2012;109:824-30.
PubMed Text format Related articles Abstract available

MEEKS JJ , Zhao LC, Cashy J, Kundu S, et al
Incidence and outcomes of ductal carcinoma of the prostate in the USA: analysis of data from the Surveillance, Epidemiology, and End Results program.
BJU Int. 2012;109:831-4.
PubMed Text format Related articles Abstract available

February 2012

BHINDI B , Trottier G, Elharram M, Fernandes KA, et al
Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): a new risk factor for prostate cancer.
BJU Int. 2012 Feb 28. doi: 10.1111/j.1464-410X.2012.10957.
PubMed Text format Related articles Abstract available

PINTHUS JH , Farrokhyar F, Hassouna MM, Woods E, et al
Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.
BJU Int. 2012 Feb 28. doi: 10.1111/j.1464-410X.2012.10945.
PubMed Text format Related articles Abstract available

GARNICK MB
PROSTATE-SPECIFIC ANTIGEN RESPONSE TO DEFERRED COMBINED ANDROGEN BLOCKADE THERAPY USING BICALUTAMIDE PREDICTS SURVIVAL AFTER SUBSEQUENT OESTROGEN AND DOCETAXEL THERAPIES IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER.
BJU Int. 2012 Feb 28. doi: 10.1111/j.1464-410X.2012.11061.
PubMed Text format Related articles

KIJIMA T , Fujii Y, Yokoyama M, Ishioka J, et al
Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
BJU Int. 2012 Feb 28. doi: 10.1111/j.1464-410X.2012.10959.
PubMed Text format Related articles Abstract available

MUNDY AR , Andrich DE
Posterior urethral complications of the treatment of prostate cancer.
BJU Int. 2012 Feb 17. doi: 10.1111/j.1464-410X.2011.10864.
PubMed Text format Related articles Abstract available

DALLAS NL , Malone PR, Jones A, Doggart AJ, et al
The results of real-time brachytherapy for the management of low- and intermediate-risk prostate cancer in patients with prostate volumes up to 100 mL.
BJU Int. 2012 Feb 14. doi: 10.1111/j.1464-410X.2012.10931.
PubMed Text format Related articles Abstract available

PALISAAR JR , Noldus J, Loppenberg B, von Bodman C, et al
Comprehensive report on prostate cancer misclassification by 16 currently used low-risk and active surveillance criteria.
BJU Int. 2012 Feb 7. doi: 10.1111/j.1464-410X.2012.10935.
PubMed Text format Related articles Abstract available

SCHILLING D , Hennenlotter J, Gakis G, Schwentner C, et al
Prospective assessment of histological serial sectioning of pelvic lymph nodes in prostate cancer: a cost-benefit analysis.
BJU Int. 2012 Feb 7. doi: 10.1111/j.1464-410X.2012.10928.
PubMed Text format Related articles Abstract available

DHANI NC , Emmenegger U, Adams L, Jongstra J, et al
Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.
BJU Int. 2012 Feb 7. doi: 10.1111/j.1464-410X.2011.10922.
PubMed Text format Related articles Abstract available

POPERT R
COMPREHENSIVE REPORT ON PROSTATE CANCER MISCLASSIFICATION BY 16 CURRENTLY USED LOW-RISK AND ACTIVE SURVEILLANCE CRITERIA.
BJU Int. 2012 Feb 7. doi: 10.1111/j.1464-410X.2012.10956.
PubMed Text format Related articles

ODERDA M , Joniau S, Spahn M, Gontero P, et al
Debulking surgery in the setting of very high-risk prostate cancer scenarios.
BJU Int. 2012 Feb 7. doi: 10.1111/j.1464-410X.2012.10942.
PubMed Text format Related articles Abstract available

TSENG CH
Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study.
BJU Int. 2012 Feb 2. doi: 10.1111/j.1464-410X.2011.10924.
PubMed Text format Related articles Abstract available

GOMEZ-VEIGA F , Marino A, Alvarez L, Rodriguez I, et al
Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy.
BJU Int. 2012;109 Suppl 1:17-21.
PubMed Text format Related articles Abstract available

GHANI KR , Trinh QD, Menon M
The phantom menace of prostate cancer screening.
BJU Int. 2012;109:324-6.
PubMed Text format Related articles

CARTER HB
PROSTATE-SPECIFIC ANTIGEN VELOCITY (PSAV) RISK COUNT IMPROVES THE SPECIFICITY OF SCREENING FOR CLINICALLY SIGNIFICANT PROSTATE CANCER.
BJU Int. 2012 Feb 1. doi: 10.1111/j.1464-410X.2011.10908.
PubMed Text format Related articles

LOEB S , Metter EJ, Kan D, Roehl KA, et al
Prostate-specific antigen velocity (PSAV) risk count improves the specificity of screening for clinically significant prostate cancer.
BJU Int. 2012 Feb 1. doi: 10.1111/j.1464-410X.2011.10900.
PubMed Text format Related articles Abstract available

HELLAWELL GO , Bhardwa J
Is it time to miss the target for prostate cancer?
BJU Int. 2012;109:492-3.
PubMed Text format Related articles

GRIMM P , Billiet I, Bostwick D, Dicker AP, et al
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.
BJU Int. 2012;109 Suppl 1:22-9.
PubMed Text format Related articles Abstract available

LANGLEY S , Ahmed HU, Al-Qaisieh B, Bostwick D, et al
Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer.
BJU Int. 2012;109 Suppl 1:7-16.
PubMed Text format Related articles Abstract available

EMBERTON M
Contemporary practice, however, bears little resemblance to those fi rst treated cases. Foreword.
BJU Int. 2012;109 Suppl 1:v.
PubMed Text format Related articles

LANGLEY SE , Laing RW
4D Brachytherapy, a novel real-time prostate brachytherapy technique using stranded and loose seeds.
BJU Int. 2012;109 Suppl 1:1-6.
PubMed Text format Related articles Abstract available

PAL RP , Elmussareh M, Chanawani M, Khan MA, et al
The role of a standardized 36 core template-assisted transperineal prostate biopsy technique in patients with previously negative transrectal ultrasonography-guided prostate biopsies.
BJU Int. 2012;109:367-71.
PubMed Text format Related articles Abstract available

VESEY SG , McCabe JE, Hounsome L, Fowler S, et al
UK radical prostatectomy outcomes and surgeon case volume: based on an analysis of the British Association of Urological Surgeons Complex Operations Database.
BJU Int. 2012;109:346-54.
PubMed Text format Related articles Abstract available

TEWARI A , Grover S, Sooriakumaran P, Srivastava A, et al
Nerve sparing can preserve orgasmic function in most men after robotic-assisted laparoscopic radical prostatectomy.
BJU Int. 2012;109:596-602.
PubMed Text format Related articles Abstract available

YUH B , Wu H, Ruel N, Wilson T, et al
Analysis of regional lymph nodes in periprostatic fat following robot-assisted radical prostatectomy.
BJU Int. 2012;109:603-7.
PubMed Text format Related articles Abstract available

BASTIDE C , Rossi D, Lechevallier E, Bladou F, et al
Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy?
BJU Int. 2012;109:525-30.
PubMed Text format Related articles Abstract available

MOORE BM , Savdie R, PeBenito RA, Haynes AM, et al
The impact of nerve sparing on incidence and location of positive surgical margins in radical prostatectomy.
BJU Int. 2012;109:533-8.
PubMed Text format Related articles Abstract available

January 2012

ROSS AE , Feng Z, Pierorazio PM, Landis P, et al
Effect of treatment with 5-alpha reductase inhibitors on progression in monitored men with favourable-risk prostate cancer.
BJU Int. 2012 Jan 30. doi: 10.1111/j.1464-410X.2011.10875.
PubMed Text format Related articles Abstract available

VAN LEEUWEN PJ , Otto SJ, Kranse R, Roobol MJ, et al
Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.
BJU Int. 2012 Jan 30. doi: 10.1111/j.1464-410X.2011.10811.
PubMed Text format Related articles Abstract available

VAN DEN BERGH RC , Korfage IJ, Roobol MJ, Bangma CH, et al
Sexual function with localized prostate cancer: active surveillance vs radical therapy.
BJU Int. 2012 Jan 19. doi: 10.1111/j.1464-410X.2011.10846.
PubMed Text format Related articles Abstract available

GARCIA-CRUZ E , Piqueras M, Ribal MJ, Huguet J, et al
Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia.
BJU Int. 2012 Jan 18. doi: 10.1111/j.1464-410X.2011.10876.
PubMed Text format Related articles Abstract available

DENIS L , Joniau S, Bossi A, Baskin-Bey E, et al
PCA: Prostate Cancer, Patient-Centred Approach or both?
BJU Int. 2012 Jan 11. doi: 10.1111/j.1464-410X.2011.10859.
PubMed Text format Related articles Abstract available

DURAND X , Xylinas E, Radulescu C, Haus-Cheymol R, et al
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy.
BJU Int. 2012 Jan 5. doi: 10.1111/j.1464-410X.2011.10682.
PubMed Text format Related articles Abstract available

MURPHY DG , Walton TJ, Connolly S, Costello AJ, et al
Focal therapy for localised prostate cancer: are we asking the correct research questions?
BJU Int. 2012;109:1-3.
PubMed Text format Related articles

ANTONARAKIS ES , Feng Z, Trock BJ, Humphreys EB, et al
The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up.
BJU Int. 2012;109:32-9.
PubMed Text format Related articles Abstract available

DONOVAN MJ , Khan FM, Powell D, Bayer-Zubek V, et al
Postoperative systems models more accurately predict risk of significant disease progression than standard risk groups and a 10-year postoperative nomogram: potential impact on the receipt of adjuvant therapy after surgery.
BJU Int. 2012;109:40-5.
PubMed Text format Related articles Abstract available

GANESAMONI R , Kumar S, Singh SK
How can we predict lymphorrhoea and clinically significant lymphoceles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications.
BJU Int. 2012;109:E6.
PubMed Text format Related articles

KINSELLA J , Acher P, Ashfield A, Chatterton K, et al
Demonstration of erectile management techniques to men scheduled for radical prostatectomy reduces long-term regret: a comparative cohort study.
BJU Int. 2012;109:254-8.
PubMed Text format Related articles Abstract available

THOMAS C , Pfirrmann K, Pieles F, Bogumil A, et al
Predictors for clinically relevant Gleason score upgrade in patients undergoing radical prostatectomy.
BJU Int. 2012;109:214-9.
PubMed Text format Related articles Abstract available

December 2011

NICKEL JC , Speakman M
SHOULD WE REALLY CONSIDER GLEASON 6 PROSTATE CANCER?
BJU Int. 2011 Dec 22. doi: 10.1111/j.1464-410X.2011.10854.
PubMed Text format Related articles

NEVOUX P , Ouzzane A, Ahmed HU, Emberton M, et al
Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series.
BJU Int. 2011 Dec 22. doi: 10.1111/j.1464-410X.2011.10776.
PubMed Text format Related articles Abstract available

WILLIAMS SB , Lei Y, Nguyen PL, Gu X, et al
Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer.
BJU Int. 2011 Dec 22. doi: 10.1111/j.1464-410X.2011.10775.
PubMed Text format Related articles Abstract available

KILMINSTER S , Muller S, Menon M, Joseph JV, et al
Predicting erectile function outcome in men after radical prostatectomy for prostate cancer.
BJU Int. 2011 Dec 19. doi: 10.1111/j.1464-410X.2011.10757.
PubMed Text format Related articles Abstract available

DI LORENZO G , Ferro M, Buonerba C
Sipuleucel-T (Provenge(R)) for castration-resistant prostate cancer.
BJU Int. 2011 Dec 16. doi: 10.1111/j.1464-410X.2011.10790.
PubMed Text format Related articles Abstract available

SARTOR O
SIPULEUCEL-T (PROVENGE(R)) FOR CASTRATION-RESISTANT PROSTATE CANCER.
BJU Int. 2011 Dec 16. doi: 10.1111/j.1464-410X.2011.10820.
PubMed Text format Related articles

GOH AC , Kowalkowski MA, Bailey Jr DE, Kazer MW, et al
Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
BJU Int. 2011 Dec 7. doi: 10.1111/j.1464-410X.2011.10791.
PubMed Text format Related articles Abstract available

Nepal Trek Raises Funds for Prostate Cancer Research: 'There are no easy walks in the Himalayas'.
BJU Int. 2011;108:ii-vii.
PubMed Text format Related articles

CARTER HB
Management of low (favourable)-risk prostate cancer.
BJU Int. 2011;108:1684-95.
PubMed Text format Related articles Abstract available

YATES DR , Vaessen C, Roupret M
From Leonardo to da Vinci: the history of robot-assisted surgery in urology.
BJU Int. 2011;108:1708-13.
PubMed Text format Related articles Abstract available

TAVERNA G , Morandi G, Seveso M, Giusti G, et al
Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
BJU Int. 2011;108:1723-7.
PubMed Text format Related articles Abstract available

CRAWFORD ED , Moul JW, Rove KO, Pettaway CA, et al
Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone.
BJU Int. 2011;108:1743-9.
PubMed Text format Related articles Abstract available

ALKHATEEB S , Lawrentschuk N
Consumerism and its impact on robotic-assisted radical prostatectomy.
BJU Int. 2011;108:1874-8.
PubMed Text format Related articles Abstract available

CHOI HC , Park JH, Cho BL, Son KY, et al
The illusion of prostate-specific antigen decline in patients with metabolic syndrome and insulin resistance.
BJU Int. 2011;108:1756-61.
PubMed Text format Related articles Abstract available

ABDOLLAH F , Sun M, Briganti A, Thuret R, et al
Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy.
BJU Int. 2011;108:1769-75.
PubMed Text format Related articles Abstract available

ADAM A , Engelbrecht MJ, Bornman MS, Manda SO, et al
The role of the PCA3 assay in predicting prostate biopsy outcome in a South African setting.
BJU Int. 2011;108:1728-33.
PubMed Text format Related articles Abstract available

November 2011

DJAVAN B , Eastham J, Gomella L, Tombal B, et al
Testosterone in prostate cancer: the Bethesda consensus.
BJU Int. 2011 Nov 30. doi: 10.1111/j.1464-410X.2011.10719.
PubMed Text format Related articles Abstract available

KATTAN MW , Potters L
VALIDATION AND COMPARISON OF THE TWO KATTAN NOMOGRAMS IN PATIENTS WITH PROSTATE CANCER TREATED WITH (125) IODINE BRACHYTHERAPY.
BJU Int. 2011 Nov 24. doi: 10.1111/j.1464-410X.2011.10758.
PubMed Text format Related articles

KAPLAN A , German L, Chen J, Matzkin H, et al
Validation and comparison of the two Kattan nomograms in patients with prostate cancer treated with (125) iodine brachytherapy.
BJU Int. 2011 Nov 24. doi: 10.1111/j.1464-410X.2011.10748.
PubMed Text format Related articles Abstract available

VAN VUGT HA , Roobol MJ, van der Poel HG, van Muilekom EH, et al
Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.
BJU Int. 2011 Nov 23. doi: 10.1111/j.1464-410X.2011.10679.
PubMed Text format Related articles Abstract available

SIMMONS LA , Autier P, Zat'ura F, Braeckman J, et al
Detection, localisation and characterisation of prostate cancer by Prostate HistoScanning().
BJU Int. 2011 Nov 17. doi: 10.1111/j.1464-410X.2011.10734.
PubMed Text format Related articles Abstract available

HONG SK , Oh JJ, Byun SS, Hwang SI, et al
Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of </=10 ng/mL.
BJU Int. 2011 Nov 17. doi: 10.1111/j.1464-410X.2011.10764.
PubMed Text format Related articles Abstract available

GALLINA A , Maccagnano C, Suardi N, Capitanio U, et al
Unilateral positive biopsies in low risk prostate cancer patients diagnosed with extended transrectal ultrasound-guided biopsy schemes do not predict unilateral prostate cancer at radical prostatectomy.
BJU Int. 2011 Nov 17. doi: 10.1111/j.1464-410X.2011.10762.
PubMed Text format Related articles Abstract available

GARNICK MB , Mottet N
New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone suppression followed by a luteinizing hormone-releasing hormone agonist.
BJU Int. 2011 Nov 16. doi: 10.1111/j.1464-410X.2011.10708.
PubMed Text format Related articles Abstract available

LOWRANCE WT , Elkin EB, Yee DS, Feifer A, et al
Locally advanced prostate cancer: a population-based study of treatment patterns.
BJU Int. 2011 Nov 15. doi: 10.1111/j.1464-410X.2011.10760.
PubMed Text format Related articles Abstract available

NGUYEN PL , Chen MH, Hoffman KE, Chen RC, et al
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.
BJU Int. 2011 Nov 15. doi: 10.1111/j.1464-410X.2011.10709.
PubMed Text format Related articles Abstract available

NICHOL MB , Wu J, Huang J, Denham D, et al
Cost-effectiveness of Prostate Health Index for prostate cancer detection.
BJU Int. 2011 Nov 11. doi: 10.1111/j.1464-410X.2011.10751.
PubMed Text format Related articles Abstract available

MCGUIRE BB , Helfand BT, Kundu S, Hu Q, et al
Association of prostate cancer risk alleles with unfavourable pathological characteristics in potential candidates for active surveillance.
BJU Int. 2011 Nov 11. doi: 10.1111/j.1464-410X.2011.10750.
PubMed Text format Related articles Abstract available

KHAN MA
GENERAL APPLICATION OF THE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE (NICE) GUIDANCE FOR ACTIVE SURVEILLANCE FOR MEN WITH PROSTATE CANCER IS NOT APPROPRIATE IN UNSCREENED POPULATIONS.
BJU Int. 2011 Nov 11. doi: 10.1111/j.1464-410X.2011.10732.
PubMed Text format Related articles

WONG LM , Johnston R, Sharma N, Shah NC, et al
General application of the National Institute for Health and Clinical Excellence (NICE) guidance for active surveillance for men with prostate cancer is not appropriate in unscreened populations.
BJU Int. 2011 Nov 11. doi: 10.1111/j.1464-410X.2011.10730.
PubMed Text format Related articles Abstract available

WASHINGTON SL , Bonham M, Whitson JM, Cowan JE, et al
Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
BJU Int. 2011 Nov 11. doi: 10.1111/j.1464-410X.2011.10704.
PubMed Text format Related articles Abstract available

AHMED HU , Akin O, Coleman JA, Crane S, et al
Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.
BJU Int. 2011 Nov 11. doi: 10.1111/j.1464-410X.2011.10633.
PubMed Text format Related articles Abstract available

CHING CB , Zaytoun O, Moussa AS, Li J, et al
Type of transrectal ultrasonography probe influences prostate cancer detection rates on repeat prostate biopsy.
BJU Int. 2011 Nov 1. doi: 10.1111/j.1464-410X.2011.10689.
PubMed Text format Related articles Abstract available

VASARAINEN H , Lokman U, Ruutu M, Taari K, et al
Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial.
BJU Int. 2011 Nov 1. doi: 10.1111/j.1464-410X.2011.10677.
PubMed Text format Related articles Abstract available

Moustaches promote men's health: Global foundation supports prostate cancer research and education.
BJU Int. 2011;108:ii-vii.
PubMed Text format Related articles

LOKE TW , Sevfi D, Khadra M
Prostate cancer incidence in Australia correlates inversely with solar radiation.
BJU Int. 2011;108 Suppl 2:66-70.
PubMed Text format Related articles Abstract available

COHEN RJ , O'Brien BA
Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
BJU Int. 2011;108 Suppl 2:56-7.
PubMed Text format Related articles

TAMBLYN DJ , Chopra S, Yu C, Kattan MW, et al
Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
BJU Int. 2011;108 Suppl 2:51-6.
PubMed Text format Related articles Abstract available

NICOL D
Editor's comment: In this edition papers cover a range of topics including urolithiasis, prostate cancer and surgery as well as training.
BJU Int. 2011;108 Suppl 2:1.
PubMed Text format Related articles

TAYLOR K , Filgate R, Guo DY, Macneil F, et al
A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs.
BJU Int. 2011;108 Suppl 2:45-50.
PubMed Text format Related articles Abstract available

FITZPATRICK JM
Getting men to talk about their health.
BJU Int. 2011;108:i.
PubMed Text format Related articles

NILSSON AE , Schumacher MC, Johansson E, Carlsson S, et al
Age at surgery, educational level and long-term urinary incontinence after radical prostatectomy.
BJU Int. 2011;108:1572-7.
PubMed Text format Related articles Abstract available

WILLIAMS N , Hughes LJ, Turner EL, Donovan JL, et al
Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
BJU Int. 2011;108:1402-8.
PubMed Text format Related articles Abstract available

TSENG KS , Landis P, Brimo F, Partin AW, et al
Repeat prostate biopsies predict location of index cancer in an active surveillance cohort.
BJU Int. 2011;108:1415-20.
PubMed Text format Related articles Abstract available

VON BODMAN C , Matsushita K, Matikainen MP, Eastham JA, et al
Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy?
BJU Int. 2011;108:1566-71.
PubMed Text format Related articles Abstract available

SHAH K , Abaza R
Comparison of intraoperative outcomes using the new and old generation da Vinci(R) robot for robot-assisted laparoscopic prostatectomy.
BJU Int. 2011;108:1642-5.
PubMed Text format Related articles Abstract available

GUPTA NP , Singh P, Nayyar R
Outcomes of robot-assisted radical prostatectomy in men with previous transurethral resection of prostate.
BJU Int. 2011;108:1501-5.
PubMed Text format Related articles Abstract available

October 2011

EADE TN , Guo L, Forde E, Vaux K, et al
Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: treating to doses beyond 78 Gy.
BJU Int. 2011 Oct 28. doi: 10.1111/j.1464-410X.2011.10668.
PubMed Text format Related articles Abstract available

LEE DJ , Cha EK, Dubin JM, Beltran H, et al
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
BJU Int. 2011 Oct 28. doi: 10.1111/j.1464-410X.2011.10643.
PubMed Text format Related articles Abstract available

WARD JF , Jones JS
Focal cryotherapy for localized prostate cancer: a report from the national Cryo On-Line Database (COLD) Registry.
BJU Int. 2011 Oct 28. doi: 10.1111/j.1464-410X.2011.10578.
PubMed Text format Related articles Abstract available

MCGUIRE BB , Helfand BT, Loeb S, Hu Q, et al
Outcomes in patients with Gleason score 8-10 prostate cancer: relation to preoperative PSA level.
BJU Int. 2011 Oct 21. doi: 10.1111/j.1464-410X.2011.10628.
PubMed Text format Related articles Abstract available

MAZZOLA C , Savage C, Ahallal Y, Reuter VE, et al
Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors.
BJU Int. 2011 Oct 12. doi: 10.1111/j.1464-410X.2011.10610.
PubMed Text format Related articles Abstract available

CONNOLLY SS , Cathcart PJ, Gilmore P, Kerger M, et al
Robotic radical prostatectomy as the initial step in multimodal therapy for men with high-risk localized prostate cancer: initial experience of 160 men.
BJU Int. 2011 Oct 12. doi: 10.1111/j.1464-410X.2011.10548.
PubMed Text format Related articles Abstract available

SPIESS PE , Given RW, Jones JS
Achieving the 'bifecta' using salvage cryotherapy for locally recurrent prostate cancer: analysis of the Cryo On-Line Data (COLD) Registry data.
BJU Int. 2011 Oct 12. doi: 10.1111/j.1464-410X.2011.10659.
PubMed Text format Related articles Abstract available

VAN DER SLUIS TM , Meuleman EJ, van Moorselaar RJ, Bui HN, et al
Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
BJU Int. 2011 Oct 12. doi: 10.1111/j.1464-410X.2011.10652.
PubMed Text format Related articles Abstract available

VAN DER SLUIS TM , Vis AN, van Moorselaar RJ, Bui HN, et al
Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
BJU Int. 2011 Oct 12. doi: 10.1111/j.1464-410X.2011.10651.
PubMed Text format Related articles Abstract available

POWELL IJ
Germline cag repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.
BJU Int. 2011;108:1092.
PubMed Text format Related articles

LOPHATANANON A , Tyndale-Biscoe S, Malcolm E, Rippon HJ, et al
THE JAMES LIND ALLIANCE APPROACH TO PRIORITY SETTING FOR PROSTATE CANCER RESEARCH: AN INTEGRATIVE METHODOLOGY BASED ON PATIENT AND CLINICIAN PARTICIPATION.
BJU Int. 2011;108:1040-1043.
PubMed Text format Related articles

SMITH JA
Incidence of lymphoceles after robot-assisted pelvic lymph node dissection.
BJU Int. 2011;108:1190.
PubMed Text format Related articles

ORVIETO MA , Coelho RF, Chauhan S, Palmer KJ, et al
Incidence of lymphoceles after robot-assisted pelvic lymph node dissection.
BJU Int. 2011;108:1185-90.
PubMed Text format Related articles Abstract available

TOUIJER K
Positive surgical margin rate, location, and size following laparoscopic versus robotic-assisted laparoscopic radical prostatectomy.
BJU Int. 2011;108:1178-9.
PubMed Text format Related articles

KASRAEIAN A , Barret E, Chan J, Sanchez-Salas R, et al
Comparison of the rate, location and size of positive surgical margins after laparoscopic and robot-assisted laparoscopic radical prostatectomy.
BJU Int. 2011;108:1174-8.
PubMed Text format Related articles Abstract available

GONTERO P , Spahn M, Tombal B, Bader P, et al
Is there a prostate-specific antigen upper limit for radical prostatectomy?
BJU Int. 2011;108:1093-100.
PubMed Text format Related articles Abstract available

CHALLACOMBE B , Dasgupta P, Patel U, Amoroso P, et al
Recognizing and managing the complications of prostate biopsy.
BJU Int. 2011;108:1233-4.
PubMed Text format Related articles

ELSHAL AM , Barakat TS, Mosbah A, Abdel-Latif M, et al
Complications of radical cysto-urethrectomy using modified Clavien grading system: prepubic versus perineal urethrectomy.
BJU Int. 2011;108:1297-300.
PubMed Text format Related articles Abstract available

BUDAUS L , Spethmann J, Isbarn H, Schmitges J, et al
Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade.
BJU Int. 2011;108:1256-61.
PubMed Text format Related articles Abstract available

RITCH CR , Hruby G, Badani KK, Benson MC, et al
Effect of statin use on biochemical outcome following radical prostatectomy.
BJU Int. 2011;108.
PubMed Text format Related articles Abstract available

CORCORAN NM , Hong MK, Casey RG, Hurtado-Coll A, et al
Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence.
BJU Int. 2011;108.
PubMed Text format Related articles Abstract available

September 2011

BOETTCHER M , Haselhuhn A, Jakse G, Brehmer B, et al
Overactive bladder syndrome: an underestimated long-term problem after treatment of patients with localized prostate cancer?
BJU Int. 2011 Sep 27. doi: 10.1111/j.1464-410X.2011.10623.
PubMed Text format Related articles Abstract available

GNANAPRAGASAM VJ , Mason MD, Shaw GL, Neal DE, et al
The role of surgery in high-risk localised prostate cancer.
BJU Int. 2011 Sep 27. doi: 10.1111/j.1464-410X.2011.10596.
PubMed Text format Related articles Abstract available

AUPRICH M , Augustin H, Budaus L, Kluth L, et al
A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
BJU Int. 2011 Sep 21. doi: 10.1111/j.1464-410X.2011.10584.
PubMed Text format Related articles Abstract available

XIE SW , Li HL, Du J, Xia JG, et al
Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography.
BJU Int. 2011 Sep 21. doi: 10.1111/j.1464-410X.2011.10577.
PubMed Text format Related articles Abstract available

SHUKLA-DAVE A , Hricak H, Akin O, Yu C, et al
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.
BJU Int. 2011 Sep 20. doi: 10.1111/j.1464-410X.2011.10612.
PubMed Text format Related articles Abstract available

VAN VUGT HA , Roobol MJ, Busstra M, Kil P, et al
Compliance with biopsy recommendations of a prostate cancer risk calculator.
BJU Int. 2011 Sep 20. doi: 10.1111/j.1464-410X.2011.10611.
PubMed Text format Related articles Abstract available

SERVOLL E , Saeter T, Vlatkovic L, Lund T, et al
Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancer.
BJU Int. 2011 Sep 20. doi: 10.1111/j.1464-410X.2011.10583.
PubMed Text format Related articles Abstract available

ALIFRANGIS C , O'Hanlon-Brown C, Tuthill M, Waxman J, et al
New drugs for prostate cancer.
BJU Int. 2011 Sep 20. doi: 10.1111/j.1464-410X.2011.10570.
PubMed Text format Related articles Abstract available

NOBES JP , Langley SE, Klopper T, Russell-Jones D, et al
A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy.
BJU Int. 2011 Sep 20. doi: 10.1111/j.1464-410X.2011.10555.
PubMed Text format Related articles Abstract available

JO Y , Fujii T, Hara R, Yokoyama T, et al
Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy - preliminary results.
BJU Int. 2011 Sep 20. doi: 10.1111/j.1464-410X.2011.10519.
PubMed Text format Related articles Abstract available

PARK M , You D, Yoon JH, Jeong IG, et al
Does repeat biopsy affect the prognosis of patients with prostate cancer treated with radical prostatectomy? Analysis by the number of cores taken at initial biopsy.
BJU Int. 2011 Sep 20. doi: 10.1111/j.1464-410X.2011.10442.
PubMed Text format Related articles Abstract available

CARTER HB
Management of low (favourable)-risk prostate cancer.
BJU Int. 2011 Sep 6. doi: 10.1111/j.1464-410X.2011.10489.
PubMed Text format Related articles Abstract available

CHAMIE K , Kwan L, Connor SE, Zavala M, et al
The impact of social networks and partnership status on treatment choice in men with localized prostate cancer.
BJU Int. 2011 Sep 2. doi: 10.1111/j.1464-410X.2011.10515.
PubMed Text format Related articles Abstract available

COLIN P , Nevoux P, Marqa M, Auger F, et al
Focal laser interstitial thermotherapy (LITT) at 980 nm for prostate cancer: treatment feasibility in Dunning R3327-AT2 rat prostate tumour.
BJU Int. 2011 Sep 2. doi: 10.1111/j.1464-410X.2011.10406.
PubMed Text format Related articles Abstract available

PICKARD R
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer.
BJU Int. 2011;108:856-7.
PubMed Text format Related articles

ROEHRBORN CG , Black LK
The economic burden of prostate cancer.
BJU Int. 2011;108:806-13.
PubMed Text format Related articles Abstract available

HENNENBERG M , Strittmatter F, Walther S, Hedlund P, et al
alpha1-adrenoceptor activation induces phosphorylation of beta2-adrenoceptors in human prostate tissue.
BJU Int. 2011;108:922-8.
PubMed Text format Related articles Abstract available

BUDAUS L , Abdollah F, Sun M, Johal R, et al
The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population-based study.
BJU Int. 2011;108:888-93.
PubMed Text format Related articles Abstract available

PATEL VR , Abdul-Muhsin HM, Schatloff O, Coelho RF, et al
Critical review of 'pentafecta' outcomes after robot-assisted laparoscopic prostatectomy in high-volume centres.
BJU Int. 2011;108.
PubMed Text format Related articles Abstract available

MOTTRIE A , Gallina A, De Wil P, Thuer D, et al
Balancing continence function and oncological outcomes during robot-assisted radical prostatectomy (RARP).
BJU Int. 2011;108.
PubMed Text format Related articles Abstract available

DAVIS JW , Shah JB, Achim M
Robot-assisted extended pelvic lymph node dissection (PLND) at the time of radical prostatectomy (RP): a video-based illustration of technique, results, and unmet patient selection needs.
BJU Int. 2011;108.
PubMed Text format Related articles Abstract available

TEWARI AK , Srivastava A, Huang MW, Robinson BD, et al
Anatomical grades of nerve sparing: a risk-stratified approach to neural-hammock sparing during robot-assisted radical prostatectomy (RARP).
BJU Int. 2011;108.
PubMed Text format Related articles Abstract available

CHALLACOMBE B
First 500 cases of robotic-assisted laparoscopic radical prostatectomy from a single uk centre: learning curves of two surgeons.
BJU Int. 2011;108:747-8.
PubMed Text format Related articles

MCNICHOLAS T
First 500 cases of robotic-assisted laparoscopic radical prostatectomy from a single uk centre: learning curves of two surgeons.
BJU Int. 2011;108:747.
PubMed Text format Related articles

KLOTZ L
An interview with Laurence Klotz, MD, FRCSC. Interview by John Fitzpatrick.
BJU Int. 2011;108:623-4.
PubMed Text format Related articles

PATEL T , Kirby W, Hruby G, Benson MC, et al
Heparin prophylaxis and the risk of venous thromboembolism after robotic-assisted laparoscopic prostatectomy.
BJU Int. 2011;108:729-32.
PubMed Text format Related articles Abstract available

REBUCK DA , Haywood S, McDermott K, Perry KT, et al
What is the long-term relevance of clinically detected postoperative anastomotic urine leakage after robotic-assisted laparoscopic prostatectomy?
BJU Int. 2011;108:733-8.
PubMed Text format Related articles Abstract available

SHARMA NL , Papadopoulos A, Lee D, McLoughlin J, et al
First 500 cases of robotic-assisted laparoscopic radical prostatectomy from a single UK centre: learning curves of two surgeons.
BJU Int. 2011;108:739-47.
PubMed Text format Related articles Abstract available

August 2011

BAUST JM , Klossner DP, Robilotto A, Vanbuskirk RG, et al
Vitamin D(3) cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial-mediated apoptosis and necrosis.
BJU Int. 2011 Aug 26. doi: 10.1111/j.1464-410X.2011.10408.
PubMed Text format Related articles Abstract available

VAN POPPEL H , Haese A, Graefen M, de la Taille A, et al
The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance.
BJU Int. 2011 Aug 26. doi: 10.1111/j.1464-410X.2011.10377.
PubMed Text format Related articles Abstract available

MONTIRONI R , Mazzucchelli R, Lopez-Beltran A, Scarpelli M, et al
Prostatic intraepithelial neoplasia: its morphological and molecular diagnosis and clinical significance.
BJU Int. 2011 Aug 26. doi: 10.1111/j.1464-410X.2011.010413.
PubMed Text format Related articles Abstract available

CHUNG SD , Chen YK, Wu FJ, Lin HC, et al
Hormone therapy for prostate cancer and the risk of stroke: a 5-year follow-up study.
BJU Int. 2011 Aug 24. doi: 10.1111/j.1464-410X.2011.10459.
PubMed Text format Related articles Abstract available

SCHOSTAK M , Baumunk D, Jagota A, Klopf C, et al
Time trends in prostate cancer surgery: data from an Internet-based multicentre database.
BJU Int. 2011 Aug 24. doi: 10.1111/j.1464-410X.2011.10356.
PubMed Text format Related articles Abstract available

LU L , Peters J, Roome C, Stein K, et al
Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer.
BJU Int. 2011 Aug 23. doi: 10.1111/j.1464-410X.2011.10434.
PubMed Text format Related articles Abstract available

PIERORAZIO PM , Ross AE, Han M, Epstein JI, et al
Evolution of the clinical presentation of men undergoing radical prostatectomy for high-risk prostate cancer.
BJU Int. 2011 Aug 22. doi: 10.1111/j.1464-410X.2011.10514.
PubMed Text format Related articles Abstract available

RABER M , Scattoni V, Gallina A, Freschi M, et al
Does the transrectal ultrasound probe influence prostate cancer detection in patients undergoing an extended prostate biopsy scheme? Results of a large retrospective study.
BJU Int. 2011 Aug 22. doi: 10.1111/j.1464-410X.2011.10522.
PubMed Text format Related articles Abstract available

CASO JR , Tsivian M, Mouraviev V, Kimura M, et al
Complications and postoperative events after cryosurgery for prostate cancer.
BJU Int. 2011 Aug 22. doi: 10.1111/j.1464-410X.2011.10423.
PubMed Text format Related articles Abstract available

AYRES BE , Montgomery BS, Barber NJ, Pereira N, et al
The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance.
BJU Int. 2011 Aug 19. doi: 10.1111/j.1464-410X.2011.10480.
PubMed Text format Related articles Abstract available

EMARA AM , Chadwick E, Nobes JP, Abdelbaky AM, et al
Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer.
BJU Int. 2011 Aug 19. doi: 10.1111/j.1464-410X.2011.10460.
PubMed Text format Related articles Abstract available

MILES AK , Rogers A, McCulloch T, Hodi Z, et al
Expression of the tumour antigen T21 is up-regulated in prostate cancer and is associated with tumour stage.
BJU Int. 2011 Aug 18. doi: 10.1111/j.1464-410X.2011.10407.
PubMed Text format Related articles Abstract available

SHORE N , Cookson MS, Gittelman MC
Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer.
BJU Int. 2011 Aug 18. doi: 10.1111/j.1464-410X.2011.10370.
PubMed Text format Related articles Abstract available

RODER MA , Christensen IJ, Berg KD, Gruschy L, et al
Serum testosterone level as a predictor of biochemical failure after radical prostatectomy for localized prostate cancer.
BJU Int. 2011 Aug 18. doi: 10.1111/j.1464-410X.2011.10335.
PubMed Text format Related articles Abstract available

BROCK M , von Bodman C, Sommerer F, Loppenberg B, et al
Comparison of real-time elastography with grey-scale ultrasonography for detection of organ-confined prostate cancer and extra capsular extension: a prospective analysis using whole mount sections after radical prostatectomy.
BJU Int. 2011 Aug 5. doi: 10.1111/j.1464-410X.2011.10209.
PubMed Text format Related articles Abstract available

HAYASHI N , Matsushima M, Yamamoto T, Sasaki H, et al
The impact of hypertriglyceridemia on prostate cancer development in patients aged >/=60 years.
BJU Int. 2011 Aug 4. doi: 10.1111/j.1464-410X.2011.10358.
PubMed Text format Related articles Abstract available

LARNER T
Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity?
BJU Int. 2011;108:377.
PubMed Text format Related articles

RIJO E , Pera M, Lorente JA, Arango O, et al
Urorectal fistulae following the treatment of prostate cancer.
BJU Int. 2011;108:E152-3.
PubMed Text format Related articles

TSIVIAN M , Polascik TJ
The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
BJU Int. 2011;108:371.
PubMed Text format Related articles

STEPHENSON JA , Green CA, Bukhari SS, Griffiths TR, et al
Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk?
BJU Int. 2011;108:E155.
PubMed Text format Related articles

Editorial comment: Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD registry.
BJU Int. 2011;108:512.
PubMed Text format Related articles

DHAR N , Ward JF, Cher ML, Jones JS, et al
Primary full-gland prostate cryoablation in older men (> age of 75 years): results from 860 patients tracked with the COLD Registry.
BJU Int. 2011;108:508-12.
PubMed Text format Related articles Abstract available

GRECO F , Hoda MR, Wagner S, Reichelt O, et al
Bilateral vs unilateral laparoscopic intrafascial nerve-sparing radical prostatectomy: evaluation of surgical and functional outcomes in 457 patients.
BJU Int. 2011;108:583-7.
PubMed Text format Related articles Abstract available

ABDOLLAH F , Scattoni V, Raber M, Roscigno M, et al
The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy.
BJU Int. 2011;108:366-71.
PubMed Text format Related articles Abstract available

SCHREIBER D , Rineer J, Sura S, Teper E, et al
Radical prostatectomy for cT3-4 disease: an evaluation of the pathological outcomes and patterns of care for adjuvant radiation in a national cohort.
BJU Int. 2011;108:360-5.
PubMed Text format Related articles Abstract available

YEE DS , Shariat SF, Lowrance WT, Maschino AC, et al
Prognostic significance of lymphovascular invasion in radical prostatectomy specimens.
BJU Int. 2011;108:502-7.
PubMed Text format Related articles Abstract available

OU YC , Yang CR, Wang J, Yang CK, et al
The learning curve for reducing complications of robotic-assisted laparoscopic radical prostatectomy by a single surgeon.
BJU Int. 2011;108:420-5.
PubMed Text format Related articles Abstract available

July 2011

CAPITANIO U , Suardi N, Briganti A, Gallina A, et al
Influence of obesity on tumour volume in patients with prostate cancer.
BJU Int. 2011 Jul 20. doi: 10.1111/j.1464-410X.2011.10453.
PubMed Text format Related articles Abstract available

PETERSEN LF , Brockton NT, Bakkar A, Liu S, et al
Elevated physiological levels of folic acid can increase in vitro growth and invasiveness of prostate cancer cells.
BJU Int. 2011 Jul 19. doi: 10.1111/j.1464-410X.2011.10437.
PubMed Text format Related articles Abstract available

GALLAGHER DJ , Cronin AM, Milowsky MI, Morris MJ, et al
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.
BJU Int. 2011 Jul 14. doi: 10.1111/j.1464-410X.2011.10292.
PubMed Text format Related articles Abstract available

RAVERY V , Fizazi K, Oudard S, Drouet L, et al
The use of estramustine phosphate in the modern management of advanced prostate cancer.
BJU Int. 2011 Jul 14. doi: 10.1111/j.1464-410X.2011.10201.
PubMed Text format Related articles Abstract available

KOPP RP , Han M, Partin AW, Humphreys E, et al
Obesity and prostate enlargement in men with localized prostate cancer.
BJU Int. 2011 Jul 8. doi: 10.1111/j.1464-410X.2011.10227.
PubMed Text format Related articles Abstract available

KO JS , Landis P, Carter HB, Partin AW, et al
Effect of intra-observer variation in prostate volume measurement on prostate-specific antigen density calculations among prostate cancer active surveillance participants.
BJU Int. 2011 Jul 8. doi: 10.1111/j.1464-410X.2011.10223.
PubMed Text format Related articles Abstract available

DONOVAN MJ , Khan FM, Bayer-Zubek V, Powell D, et al
A systems-based modelling approach using transurethral resection of the prostate (TURP) specimens yielded incremental prognostic significance to Gleason when predicting long-term outcome in men with localized prostate cancer.
BJU Int. 2011 Jul 6. doi: 10.1111/j.1464-410X.2011.10316.
PubMed Text format Related articles Abstract available

BITTNER N , Merrick GS, Galbreath RW, Butler WM, et al
Erectile dysfunction is predictive of all-cause mortality in patients with prostate cancer treated with permanent interstitial brachytherapy.
BJU Int. 2011 Jul 6. doi: 10.1111/j.1464-410X.2011.10280.
PubMed Text format Related articles Abstract available

LOEB S
Prediction of outcomes after radical prostatectomy in patients diagnosed with prostate cancer of biopsy Gleason score >/= 8 via contemporary multi(>/=12)-core prostate biopsy.
BJU Int. 2011;108:222.
PubMed Text format Related articles

DAVIS JW , Shih YC
Trends in the care of radical prostatectomy in the United States from 2003 to 2006.
BJU Int. 2011;108:55.
PubMed Text format Related articles

WYLLIE MG
When two plus two must not equal four.
BJU Int. 2011;108:E1-2.
PubMed Text format Related articles

WILLIAMS SB , Prasad SM, Weinberg AC, Shelton JB, et al
Trends in the care of radical prostatectomy in the United States from 2003 to 2006.
BJU Int. 2011;108:49-55.
PubMed Text format Related articles Abstract available

GOLDSTEIN MR , Mascitelli L
Effect of statin use on biochemical outcome following radical prostatectomy.
BJU Int. 2011;108:E6-8.
PubMed Text format Related articles

AGARWAL N , Vogelzang NJ
Secondary hormonal manipulations in the treatment of castration refractory prostate cancer.
BJU Int. 2011;108:227-8.
PubMed Text format Related articles

LECUONA A , Heyns CF
A prospective, randomized trial comparing the Vienna nomogram to an eight-core prostate biopsy protocol.
BJU Int. 2011;108:204-8.
PubMed Text format Related articles Abstract available

PROCOPIO G , Guadalupi V, Giganti MO, Mariani L, et al
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration.
BJU Int. 2011;108:223-7.
PubMed Text format Related articles Abstract available

WITHROW DR , DeGroot JM, Siemens DR, Groome PA, et al
Therapeutic value of lymph node dissection at radical prostatectomy: a population-based case-cohort study.
BJU Int. 2011;108:209-16.
PubMed Text format Related articles Abstract available

CORNU JN , Sebe P, Ciofu C, Peyrat L, et al
Mid-term evaluation of the transobturator male sling for post-prostatectomy incontinence: focus on prognostic factors.
BJU Int. 2011;108:236-40.
PubMed Text format Related articles Abstract available

June 2011

BOUTIER R , Girouin N, Cheikh AB, Belot A, et al
Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
BJU Int. 2011 Jun 28. doi: 10.1111/j.1464-410X.2011.10251.
PubMed Text format Related articles Abstract available

MARBERGER M , Freedland SJ, Andriole GL, Emberton M, et al
Usefulness of prostate-specific antigen (PSA) rise as a marker of prostate cancer in men treated with dutasteride: lessons from the REDUCE study.
BJU Int. 2011 Jun 23. doi: 10.1111/j.1464-410X.2011.10373.
PubMed Text format Related articles Abstract available

FORBAT L , White I, Marshall-Lucette S, Kelly D, et al
Discussing the sexual consequences of treatment in radiotherapy and urology consultations with couples affected by prostate cancer.
BJU Int. 2011 Jun 1. doi: 10.1111/j.1464-410X.2011.10257.
PubMed Text format Related articles Abstract available

AFAQ A , Koh DM, Padhani A, van As N, et al
Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer.
BJU Int. 2011 Jun 1. doi: 10.1111/j.1464-410X.2011.10256.
PubMed Text format Related articles Abstract available

STONE NN
Survival after prostate brachytherapy in patients aged 60 years and younger.
BJU Int. 2011;107:1911.
PubMed Text format Related articles

HINNEN KA , Roeloffzen EM, Battermann JJ, Van Moorselaar RJ, et al
Survival after prostate brachytherapy in patients aged 60 years and younger.
BJU Int. 2011;107:1906-11.
PubMed Text format Related articles Abstract available

MAGHELI A , Gonzalgo ML, Su LM, Guzzo TJ, et al
Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching.
BJU Int. 2011;107:1956-62.
PubMed Text format Related articles Abstract available

MAHLBERG MJ , Cook J
'Mohs surgery of the prostate': the utility of in situ frozen section analysis during robotic prostatectomy.
BJU Int. 2011;107:1847-8.
PubMed Text format Related articles

LOGOTHETIS CJ
When 'dueling technologies' are mistaken for progress.
BJU Int. 2011;107:1699-700.
PubMed Text format Related articles

LEE DJ , Ritch C, Desai M, Benson MC, et al
The interaction of body mass index and race in predicting biochemical failure after radical prostatectomy.
BJU Int. 2011;107:1741-7.
PubMed Text format Related articles Abstract available

WILLIAMS SB , D'Amico AV, Weinberg AC, Gu X, et al
Population-based determinants of radical prostatectomy surgical margin positivity.
BJU Int. 2011;107:1734-40.
PubMed Text format Related articles Abstract available

PLOUSSARD G , Agamy MA, Alenda O, Allory Y, et al
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naive patients.
BJU Int. 2011;107:1748-54.
PubMed Text format Related articles Abstract available

OLIVEIRA M , Marques V, Carvalho AP, Santos A, et al
Head-to-head comparison of two online nomograms for prostate biopsy outcome prediction.
BJU Int. 2011;107:1780-3.
PubMed Text format Related articles Abstract available

May 2011

SFAKIANOS JP , Thorner DA, Dovirak O, Weiss JP, et al
Optimizing prostate cancer detection during biopsy by standardizing the amount of tissue examined per core.
BJU Int. 2011 May 31. doi: 10.1111/j.1464-410X.2011.10239.
PubMed Text format Related articles Abstract available

CAFFO O , Sava T, Comploj E, Fariello A, et al
Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trial.
BJU Int. 2011 May 26. doi: 10.1111/j.1464-410X.2011.10277.
PubMed Text format Related articles Abstract available

INMAN BA , Frank I, Boorjian SA, Akornor JW, et al
Dynamic prediction of metastases after radical prostatectomy for prostate cancer.
BJU Int. 2011 May 26. doi: 10.1111/j.1464-410X.2011.10208.
PubMed Text format Related articles Abstract available

IZUMI K , Mizokami A, Itai S, Shima T, et al
Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis.
BJU Int. 2011 May 23. doi: 10.1111/j.1464-410X.2011.10192.
PubMed Text format Related articles Abstract available

TOLONEN TT , Tammela TL, Kujala PM, Tuominen VJ, et al
Histopathological variables and biomarkers enhancer of zeste homologue 2, Ki-67 and minichromosome maintenance protein 7 as prognosticators in primarily endocrine-treated prostate cancer.
BJU Int. 2011 May 18. doi: 10.1111/j.1464-410X.2011.10253.
PubMed Text format Related articles Abstract available

MORALES A
Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry.
BJU Int. 2011;107:1369-73.
PubMed Text format Related articles

MASKO EM , Freedland SJ
Prostate cancer and diet: food for thought?
BJU Int. 2011;107:1359-60.
PubMed Text format Related articles

HORI S , Butler E, McLoughlin J
Prostate cancer and diet: food for thought?
BJU Int. 2011;107:1348-59.
PubMed Text format Related articles

MORALES A
Use of testosterone in men with prostate cancer and suggestions for an international registry.
BJU Int. 2011;107:1343-4.
PubMed Text format Related articles

HELDWEIN FL , Teloken PE, Hartmann AA, Rhoden EL, et al
Antibiotics and observation have a similar impact on asymptomatic patients with a raised PSA.
BJU Int. 2011;107:1576-81.
PubMed Text format Related articles Abstract available

MASTERSON TA , Cheng L, Koch MO
Pathological characterization of unifocal prostate cancers in whole-mount radical prostatectomy specimens.
BJU Int. 2011;107:1587-91.
PubMed Text format Related articles Abstract available

WILLIAMS AK , Chalasani V, Martinez CH, Osbourne E, et al
Cumulative summation graphs are a useful tool for monitoring positive surgical margin rates in robot-assisted radical prostatectomy.
BJU Int. 2011;107:1648-52.
PubMed Text format Related articles Abstract available

HUANG Y , Isharwal S, Haese A, Chun FK, et al
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score.
BJU Int. 2011;107:1562-9.
PubMed Text format Related articles Abstract available

SOORIAKUMARAN P , Grover S, Tewari A
The success of focal therapy hinges on the success of imaging platforms.
BJU Int. 2011;107:1344-6.
PubMed Text format Related articles

April 2011

TROTTIER G , Roobol MJ, Lawrentschuk N, Bostrom PJ, et al
Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort.
BJU Int. 2011 Apr 20. doi: 10.1111/j.1464-410X.2011.10207.
PubMed Text format Related articles Abstract available

DAVISON BJ , Goldenberg SL
Patient acceptance of active surveillance as a treatment option for low-risk prostate cancer.
BJU Int. 2011 Apr 20. doi: 10.1111/j.1464-410X.2011.10200.
PubMed Text format Related articles Abstract available

PAKKANEN S , Kujala PM, Ha N, Matikainen MP, et al
Clinical and histopathological characteristics of familial prostate cancer in Finland.
BJU Int. 2011 Apr 20. doi: 10.1111/j.1464-410X.2011.10198.
PubMed Text format Related articles Abstract available

QUON H , Loblaw A, Nam R
Dramatic increase in prostate cancer cases by 2021.
BJU Int. 2011 Apr 20. doi: 10.1111/j.1464-410X.2011.10197.
PubMed Text format Related articles Abstract available

MOURAVIEV V , Villers A, Bostwick DG, Wheeler TM, et al
Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy.
BJU Int. 2011 Apr 13. doi: 10.1111/j.1464-410X.2010.10039.
PubMed Text format Related articles Abstract available

BRACARDA S , Logothetis C, Sternberg CN, Oudard S, et al
Current and emerging treatment modalities for metastatic castration-resistant prostate cancer.
BJU Int. 2011;107 Suppl 2:13-20.
PubMed Text format Related articles Abstract available

FITZPATRICK J
Chairman's foreword: Our understanding of the biological basis of prostate cancer progression has increased significantly, providing a strong rationale for the design and development of new therapeutic agents.
BJU Int. 2011;107 Suppl 2:iii.
PubMed Text format Related articles Abstract available

FRYDENBERG M
Equity in prostate cancer screening and management.
BJU Int. 2011;107 Suppl 3:33.
PubMed Text format Related articles

POKORNY MR , Scott DJ
Do Maori and Pacific Islander men present with more advanced prostate cancer than European New Zealand men? An analysis of 486 men undergoing biopsy in Auckland.
BJU Int. 2011;107 Suppl 3:27-32.
PubMed Text format Related articles Abstract available

CATHCART P , Murphy DG, Moon D, Costello AJ, et al
Perioperative, functional and oncological outcomes after open and minimally invasive prostate cancer surgery: experience from Australasia.
BJU Int. 2011;107 Suppl 3:11-9.
PubMed Text format Related articles Abstract available

FITZPATRICK JM , Bellmunt J, Dreicer R, Fleshner NE, et al
Maximizing outcomes in genitourinary cancers across the treatment continuum.
BJU Int. 2011;107 Suppl 2:1-12.
PubMed Text format Related articles Abstract available

JEFFERIES ER , Thurairaja R, Persad RA, Rajani R, et al
Don't think once, think twice! the cardiovascular effects of androgen deprivation therapy.
BJU Int. 2011;107:1023-8.
PubMed Text format Related articles

CAPITANIO U , Pellucchi F, Gallina A, Briganti A, et al
How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications.
BJU Int. 2011;107:1095-101.
PubMed Text format Related articles Abstract available

LALLAS CD , Pe ML, Thumar AB, Chandrasekar T, et al
Comparison of lymph node yield in robot-assisted laparoscopic prostatectomy with that in open radical retropubic prostatectomy.
BJU Int. 2011;107:1136-40.
PubMed Text format Related articles Abstract available

HOSSACK T , Woo HH
Acceptance of repeat transrectal ultrasonography guided prostate biopsies with local anaesthesia.
BJU Int. 2011;107 Suppl 3:38-42.
PubMed Text format Related articles Abstract available

LIN GW , Yao XD, Ye DW
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration.
BJU Int. 2011;107:1326-7.
PubMed Text format Related articles

GONZALEZ SV , Pijuan XM
Evidence-based medicine: comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate.
BJU Int. 2011;107:1200-8.
PubMed Text format Related articles Abstract available

March 2011

KRAHN M , Bremner KE, Tomlinson G, Luo J, et al
Androgen deprivation therapy in prostate cancer: are rising concerns leading to falling use?
BJU Int. 2011 Mar 31. doi: 10.1111/j.1464-410X.2011.10127.
PubMed Text format Related articles Abstract available

LAWRENTSCHUK N , Daljeet N, Trottier G, Crawley P, et al
An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer.
BJU Int. 2011 Mar 29. doi: 10.1111/j.1464-410X.2010.09983.
PubMed Text format Related articles Abstract available

SCHIAVINA R , Manferrari F, Garofalo M, Bertaccini A, et al
The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer.
BJU Int. 2011 Mar 29. doi: 10.1111/j.1464-410X.2010.10016.
PubMed Text format Related articles Abstract available

DJAVAN B , Laze J, Eckersberger E, Finkelstein J, et al
The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer.
BJU Int. 2011 Mar 28. doi: 10.1111/j.1464-410X.2011.10173.
PubMed Text format Related articles Abstract available

TEWARI AK , Shevchuk MM, Sterling J, Grover S, et al
Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: implications in prostate cancer surgery.
BJU Int. 2011 Mar 28. doi: 10.1111/j.1464-410X.2011.10169.
PubMed Text format Related articles Abstract available

RANASINGHE WK , Sibanda T, de Silva MV, Ranasinghe TI, et al
Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England.
BJU Int. 2011 Mar 25. doi: 10.1111/j.1464-410X.2011.10165.
PubMed Text format Related articles Abstract available

CHUNG HT , Noworolski SM, Kurhanewicz J, Weinberg V, et al
A pilot study of endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging changes with dutasteride in patients with low risk prostate cancer.
BJU Int. 2011 Mar 24. doi: 10.1111/j.1464-410X.2010.10061.
PubMed Text format Related articles Abstract available

HAFFNER J , Lemaitre L, Puech P, Haber GP, et al
Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection.
BJU Int. 2011 Mar 22. doi: 10.1111/j.1464-410X.2011.10112.
PubMed Text format Related articles Abstract available

IHRIG A , Keller M, Hartmann M, Debus J, et al
Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy.
BJU Int. 2011 Mar 16. doi: 10.1111/j.1464-410X.2011.10082.
PubMed Text format Related articles Abstract available

HOOGLAND AM , Dahlman A, Vissers KJ, Wolters T, et al
Cysteine-rich secretory protein 3 and beta-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.
BJU Int. 2011 Mar 16. doi: 10.1111/j.1464-410X.2010.10059.
PubMed Text format Related articles Abstract available

MISRA D , Xie W, Regan MM, Ross RW, et al
Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.
BJU Int. 2011 Mar 16. doi: 10.1111/j.1464-410X.2010.10037.
PubMed Text format Related articles Abstract available

PETTAWAY CA , Lamerato LE, Eaddy MT, Edwards JK, et al
Benign prostatic hyperplasia: racial differences in treatment patterns and prostate cancer prevalence.
BJU Int. 2011 Mar 4. doi: 10.1111/j.1464-410X.2010.09991.
PubMed Text format Related articles Abstract available

KIRBY RS , Fitzpatrick JM
Improved survival prospects for patients with castration-resistant prostate cancer.
BJU Int. 2011;107:697-700.
PubMed Text format Related articles

ISMAIL M , Sood A, Davies J
Prognostic value of initial prostate-specific antigen levels after salvage cryoablation for prostate cancer.
BJU Int. 2011;107:1010.
PubMed Text format Related articles

CATHCART P , Connolly S, Murphy DG, Costello AJ, et al
Early oncological outcomes of robot-assisted radical prostatectomy for high-grade prostate cancer.
BJU Int. 2011;107:1009.
PubMed Text format Related articles

ILIC D , O'Connor D, Green S, Wilt TJ, et al
Screening for prostate cancer: an updated Cochrane systematic review.
BJU Int. 2011;107:882-91.
PubMed Text format Related articles Abstract available

CARMIGNANI L , Pavesi M, Picozzi S
Comparison of transfusion requirements between open and robotic-assisted laparoscopic radical prostatectomy.
BJU Int. 2011;107:853-4.
PubMed Text format Related articles

OJHA RP , Felini MJ, Singh KP, Faramawi MF, et al
Radiation therapy for localized or locally advanced prostate adenocarcinoma and myeloma incidence in a population-based cohort.
BJU Int. 2011;107:693-7.
PubMed Text format Related articles

DASGUPTA P
'Mohs surgery of the prostate': the utility of in situ frozen section analysis during robotic prostatectomy.
BJU Int. 2011;107:979.
PubMed Text format Related articles

STOLZENBURG JU , Franz T, Kallidonis P, Minh D, et al
Comparison of the FreeHand(R) robotic camera holder with human assistants during endoscopic extraperitoneal radical prostatectomy.
BJU Int. 2011;107:970-4.
PubMed Text format Related articles

LAVERY HJ , Xiao GQ, Nabizada-Pace F, Mikulasovich M, et al
'Mohs surgery of the prostate': the utility of in situ frozen section analysis during robotic prostatectomy.
BJU Int. 2011;107:975-9.
PubMed Text format Related articles

February 2011

GANZER R , Robertson CN, Ward JF, Brown SC, et al
Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.
BJU Int. 2011 Feb 18. doi: 10.1111/j.1464-410X.2011.10091.
PubMed Text format Related articles Abstract available

OON SF , Watson RW, O'Leary JJ, Fitzpatrick JM, et al
Epstein criteria for insignificant prostate cancer.
BJU Int. 2011 Feb 14. doi: 10.1111/j.1464-410X.2011.09979.
PubMed Text format Related articles Abstract available

SIDDIQUI SA , Boorjian SA, Blute ML, Rangel LJ, et al
Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
BJU Int. 2011;107:383-8.
PubMed Text format Related articles Abstract available

UCHIDA T , Shoji S, Nakano M, Hongo S, et al
High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy.
BJU Int. 2011;107:378-82.
PubMed Text format Related articles Abstract available

BERNEY DM
The tumour-node-metastasis staging of prostate cancer in transurethral resection of the prostate chips requires revision.
BJU Int. 2011;107:351-2.
PubMed Text format Related articles

TANNO T , Rabel A, Alleyne M, Lee YT, et al
Hepcidin, anaemia, and prostate cancer.
BJU Int. 2011;107:678-9.
PubMed Text format Related articles

O'BRIEN BA , Cohen RJ, Wheeler TM, Moorin RE, et al
A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis.
BJU Int. 2011;107:389-95.
PubMed Text format Related articles Abstract available

GABOARDI F , Gregori A, Santoro L, Granata A, et al
'LESS' radical prostatectomy: a pilot feasibility study with a personal original technique.
BJU Int. 2011;107:460-4.
PubMed Text format Related articles Abstract available

KUMAR P , Knight O, Lindisfarne E, Cahill D, et al
Reducing the time to continence after radical prostatectomy.
BJU Int. 2011;107:525-6.
PubMed Text format Related articles

January 2011

ZELIADT SB , Penson DF, Moinpour CM, Blough DK, et al
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer.
BJU Int. 2011 Jan 18. doi: 10.1111/j.1464-410X.2010.09945.
PubMed Text format Related articles Abstract available

BIRKHAHN M , Penson DF, Cai J, Groshen S, et al
Long-term outcome in patients with a Gleason score </=6 prostate cancer treated by radical prostatectomy.
BJU Int. 2011 Jan 12. doi: 10.1111/j.1464-410X.2010.09978.
PubMed Text format Related articles Abstract available

NGUYEN CT , Jones JS
Focal therapy in the management of localized prostate cancer.
BJU Int. 2011 Jan 11. doi: 10.1111/j.1464-410X.2010.09975.
PubMed Text format Related articles Abstract available

ALCARAZ A , Burgos FJ, Cozar JM, Gomez-Veiga F, et al
Prostate cancer in Spain: from guidelines to clinical practice.
BJU Int. 2011 Jan 11. doi: 10.1111/j.1464-410X.2010.09832.
PubMed Text format Related articles Abstract available

DUNDEE PE , Hutton AC, Eden CG
[(18) f]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
BJU Int. 2011;107:158-9.
PubMed Text format Related articles

KOMMU SS , Eden CG, Luscombe CJ, Golash A, et al
Initial treatment costs of organ-confined prostate cancer: a general perspective.
BJU Int. 2011;107:1-3.
PubMed Text format Related articles

SIMMONS L , Ahmed HU, Moore C, Emberton M, et al
Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment.
BJU Int. 2011;107:338.
PubMed Text format Related articles

KIRBY R
'Prostate action' charity created by merger of prostate uk and prostate cancer research foundation.
BJU Int. 2011;107:189-90.
PubMed Text format Related articles

NOVARA G , Ficarra V, D'Elia C, Secco S, et al
Trifecta outcomes after robot-assisted laparoscopic radical prostatectomy.
BJU Int. 2011;107:100-4.
PubMed Text format Related articles Abstract available

TURKBEY B , Xu S, Kruecker J, Locklin J, et al
Documenting the location of prostate biopsies with image fusion.
BJU Int. 2011;107:53-7.
PubMed Text format Related articles Abstract available

ABE M , Xie W, Regan MM, King IB, et al
Single-nucleotide polymorphisms within the antioxidant defence system and associations with aggressive prostate cancer.
BJU Int. 2011;107:126-34.
PubMed Text format Related articles Abstract available

ROACH M
Editorial comment.
BJU Int. 2011;107:232-3.
PubMed Text format Related articles

YONG DZ , Tsivian M, Zilberman DE, Ferrandino MN, et al
Predictors of prolonged operative time during robot-assisted laparoscopic radical prostatectomy.
BJU Int. 2011;107:280-2.
PubMed Text format Related articles Abstract available

PLOUSSARD G , de la Taille A, Xylinas E, Allory Y, et al
Prospective evaluation of combined oncological and functional outcomes after laparoscopic radical prostatectomy: trifecta rate of achieving continence, potency and cancer control at 2 years.
BJU Int. 2011;107:274-9.
PubMed Text format Related articles Abstract available

December 2010

HONG SK , Na W, Park JM, Byun SS, et al
Prediction of pathological outcomes for a single microfocal (</=3 mm) Gleason 6 prostate cancer detected via contemporary multicore (>/=12) biopsy in men with prostate-specific antigen </=10 ng/mL.
BJU Int. 2010 Dec 24. doi: 10.1111/j.1464-410X.2010.09996.
PubMed Text format Related articles Abstract available

TOUIJER K , Fuenzalida RP, Rabbani F, Paparel P, et al
Extending the indications and anatomical limits of pelvic lymph node dissection for prostate cancer: improved staging or increased morbidity?
BJU Int. 2010 Dec 24. doi: 10.1111/j.1464-410X.2010.09877.
PubMed Text format Related articles Abstract available

PLOUSSARD G , Xylinas E, Durand X, Ouzaid I, et al
Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme.
BJU Int. 2010 Dec 22. doi: 10.1111/j.1464-410X.2010.09974.
PubMed Text format Related articles Abstract available

ROSS AE , Emadi A, Marchionni L, Hurley PJ, et al
Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity.
BJU Int. 2010 Dec 22. doi: 10.1111/j.1464-410X.2010.09907.
PubMed Text format Related articles Abstract available

AHALLAL Y , Shariat SF, Chade DC, Mazzola C, et al
Pilot study of salvage laparoscopic prostatectomy for the treatment of recurrent prostate cancer.
BJU Int. 2010 Dec 16. doi: 10.1111/j.1464-410X.2010.09924.
PubMed Text format Related articles Abstract available

MADERSBACHER S , Alcaraz A, Emberton M, Hammerer P, et al
The influence of family history on prostate cancer risk: implications for clinical management.
BJU Int. 2010 Dec 16. doi: 10.1111/j.1464-410X.2010.10024.
PubMed Text format Related articles Abstract available

OKERA M , Bae K, Bernstein E, Cheng L, et al
Evaluation of nuclear factor kappaB and chemokine receptor CXCR4 co-expression in patients with prostate cancer in the Radiation Therapy Oncology Group (RTOG) 8610.
BJU Int. 2010 Dec 13. doi: 10.1111/j.1464-410X.2010.09884.
PubMed Text format Related articles Abstract available

KIRBY R , Patil K, Amoroso P, Challacombe B, et al
Avoiding and dealing with the complications of robot-assisted laparoscopic radical prostatectomy.
BJU Int. 2010;106:1567-9.
PubMed Text format Related articles

BLANCHET KD
Focal therapies and imaging: An imperfect marriage? An expert panel weighs in.
BJU Int. 2010;106:ii-vii.
PubMed Text format Related articles

KIRK D
Current prospects for the chemoprevention of prostatic cancer.
BJU Int. 2010;106:1826-7.
PubMed Text format Related articles

HOCAOGLU Y , Bastian P, Buchner A, Bauer R, et al
Impact of previous mesh hernia repair on the performance of open radical prostatectomy - complications and functional outcome.
BJU Int. 2010;106:1628-31.
PubMed Text format Related articles Abstract available

SCHOEPPLER GM , Buchner A, Zaak D, Khoder W, et al
Detection of urinary leakage after radical retropubic prostatectomy by contrast enhanced ultrasound - do we still need conventional retrograde cystography?
BJU Int. 2010;106:1632-7.
PubMed Text format Related articles Abstract available

BOTT SR , Ahmed HU, Hindley RG, Abdul-Rahman A, et al
The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer.
BJU Int. 2010;106:1607-11.
PubMed Text format Related articles Abstract available

CASO JR , Tsivian M, Mouraviev V, Polascik TJ, et al
Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer.
BJU Int. 2010;106:1623-7.
PubMed Text format Related articles Abstract available

D'AMICO AV , Chen MH, Sun L, Lee WR, et al
Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death.
BJU Int. 2010;106:1618-22.
PubMed Text format Related articles Abstract available

REHDER P , Mitterberger MJ, Pichler R, Kerschbaumer A, et al
The 1 year outcome of the transobturator retroluminal repositioning sling in the treatment of male stress urinary incontinence.
BJU Int. 2010;106:1668-72.
PubMed Text format Related articles Abstract available

November 2010

HUBER J , Ihrig A, Peters T, Huber CG, et al
Decision-making in localized prostate cancer: lessons learned from an online support group.
BJU Int. 2010 Nov 24. doi: 10.1111/j.1464-410X.2010.09859.
PubMed Text format Related articles Abstract available

MENARD J , Durlach A, Barbe C, Joseph K, et al
Endothelin-1: a predictor of extracapsular extension in clinically localized prostate cancer?
BJU Int. 2010 Nov 23. doi: 10.1111/j.1464-410X.2010.09879.
PubMed Text format Related articles Abstract available

ANTONARAKIS ES , Chen Y, Elsamanoudi SI, Brassell SA, et al
Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database.
BJU Int. 2010 Nov 23. doi: 10.1111/j.1464-410X.2010.09878.
PubMed Text format Related articles Abstract available

ANANDADAS CN , Clarke NW, Davidson SE, O'Reilly PH, et al
Early prostate cancer - which treatment do men prefer and why?
BJU Int. 2010 Nov 17. doi: 10.1111/j.1464-410X.2010.09833.
PubMed Text format Related articles Abstract available

HONG SK , Oh JJ, Jeong SJ, Jeong CW, et al
Prediction of outcomes after radical prostatectomy in patients diagnosed with prostate cancer of biopsy gleason score >/= 8 via contemporary multi (>/=12)-core prostate biopsy.
BJU Int. 2010 Nov 17. doi: 10.1111/j.1464-410X.2010.09814.
PubMed Text format Related articles Abstract available

RIPERT T , Azemar MD, Menard J, Barbe C, et al
Six years' experience with high-intensity focused ultrasonography for prostate cancer: oncological outcomes using the new 'Stuttgart' definition for biochemical failure.
BJU Int. 2010 Nov 17. doi: 10.1111/j.1464-410X.2010.09710.
PubMed Text format Related articles Abstract available

THONG MS , Van De Poll-Franse L, Hoffman RM, Albertsen PC, et al
Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study.
BJU Int. 2010 Nov 11. doi: 10.1111/j.1464-410X.2010.09861.
PubMed Text format Related articles Abstract available

RAJARUBENDRA N , Lawrentschuk N, Bolton DM, Klotz L, et al
Prostate cancer immunology - an update for Urologists.
BJU Int. 2010 Nov 10. doi: 10.1111/j.1464-410X.2010.09820.
PubMed Text format Related articles Abstract available

KORETS R , Motamedinia P, Yeshchina O, Desai M, et al
Accuracy of the Kattan nomogram across prostate cancer risk-groups.
BJU Int. 2010 Nov 9. doi: 10.1111/j.1464-410X.2010.09838.
PubMed Text format Related articles Abstract available

LIBERALE F , Muir GH, Walsh K, Krishnamoorthy R, et al
GreenLight laser prostatectomy: a safe and effective treatment for bladder outlet obstruction by prostate cancer.
BJU Int. 2010 Nov 5. doi: 10.1111/j.1464-410X.2010.09584.
PubMed Text format Related articles Abstract available

DELONGCHAMPS NB , Rouanne M, Flam T, Beuvon F, et al
Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging.
BJU Int. 2010 Nov 2. doi: 10.1111/j.1464-410X.2010.09808.
PubMed Text format Related articles Abstract available

NONOMURA N , Takayama H, Nakayama M, Nakai Y, et al
Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer.
BJU Int. 2010 Nov 2. doi: 10.1111/j.1464-410X.2010.09804.
PubMed Text format Related articles Abstract available

XYLINAS E , Ploussard G, Durand X, Fabre A, et al
Low pretreatment total testosterone (<3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer.
BJU Int. 2010 Nov 2. doi: 10.1111/j.1464-410X.2010.09816.
PubMed Text format Related articles Abstract available

KIM HJ , Lee YS, Won EH, Chang IH, et al
Expression of resistin in the prostate and its stimulatory effect on prostate cancer cell proliferation.
BJU Int. 2010 Nov 2. doi: 10.1111/j.1464-410X.2010.09813.
PubMed Text format Related articles Abstract available

TANG P , Sun L, Uhlman MA, Robertson CN, et al
Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men.
BJU Int. 2010 Nov 2. doi: 10.1111/j.1464-410X.2010.09812.
PubMed Text format Related articles Abstract available

VAN ROERMUND JG , Hinnen KA, Tolman CJ, Bol GH, et al
Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients.
BJU Int. 2010 Nov 2. doi: 10.1111/j.1464-410X.2010.09811.
PubMed Text format Related articles Abstract available

CHUKWURA MGBAKOR A , Ogbonna AO
Can lifestyle modification lower the risk of prostate cancer?
BJU Int. 2010;106:1555-6.
PubMed Text format Related articles

VERIT A
Effect of prostate size on pathological outcome and biochemical recurrence after radical prostatectomy for prostate cancer: is it correlated with serum testosterone level?
BJU Int. 2010;106:1555.
PubMed Text format Related articles

KRUPSKI TL , Stukenborg GJ, Moon K, Theodorescu D, et al
The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer.
BJU Int. 2010;106:1477-83.
PubMed Text format Related articles Abstract available

WILT TJ , Macdonald R, Hagerty K, Schellhammer P, et al
5-alpha-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review.
BJU Int. 2010;106:1444-51.
PubMed Text format Related articles Abstract available

HORI S , Sengupta A, Joannides A, Balogun-Ojuri B, et al
Changing antibiotic prophylaxis for transrectal ultrasound-guided prostate biopsies: are we putting our patients at risk?
BJU Int. 2010;106:1298-302.
PubMed Text format Related articles Abstract available

KETTERMANN AE , Ferrucci L, Trock BJ, Metter EJ, et al
Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.
BJU Int. 2010;106:1284-90.
PubMed Text format Related articles Abstract available

PLOUSSARD G , Azancot V, Nicolaiew N, Xylinas E, et al
The effect of prostate-specific antigen screening during the last decade: development of clinicopathological variables independently of the biopsy core number.
BJU Int. 2010;106:1293-7.
PubMed Text format Related articles Abstract available

MOUSSA AS , Jones JS, Yu C, Fareed K, et al
Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling.
BJU Int. 2010;106:1309-14.
PubMed Text format Related articles Abstract available

WANG L , Akin O, Mazaheri Y, Ishill NM, et al
Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?
BJU Int. 2010;106:1303-8.
PubMed Text format Related articles Abstract available

TEWARI AK , Srivastava A, Mudaliar K, Tan GY, et al
Anatomical retro-apical technique of synchronous (posterior and anterior) urethral transection: a novel approach for ameliorating apical margin positivity during robotic radical prostatectomy.
BJU Int. 2010;106:1364-73.
PubMed Text format Related articles Abstract available

MITTERBERGER M , Aigner F, Pinggera GM, Steiner E, et al
Contrast-enhanced colour Doppler-targeted prostate biopsy: correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy.
BJU Int. 2010;106:1315-8.
PubMed Text format Related articles Abstract available

MARIEN T , Taouli B, Telegrafi S, Babb J, et al
Optimizing the detection of subclinical inguinal hernias in men undergoing open radical retropubic prostatectomy.
BJU Int. 2010;106:1468-72.
PubMed Text format Related articles Abstract available

DI STASO M , Bonfili P, Gravina GL, Di Genesio Pagliuca M, et al
Late morbidity and oncological outcome after radical hypofractionated radiotherapy in men with prostate cancer.
BJU Int. 2010;106:1458-62.
PubMed Text format Related articles Abstract available

BASTIDE C , Savage C, Cronin A, Zelefsky MJ, et al
Location and number of positive surgical margins as prognostic factors of biochemical recurrence after salvage radiation therapy after radical prostatectomy.
BJU Int. 2010;106:1454-7.
PubMed Text format Related articles Abstract available

PAHLAJANI G , Raina R, Jones JS, Burdick M, et al
Early intervention with phosphodiesterase-5 inhibitors after prostate brachytherapy improves subsequent erectile function.
BJU Int. 2010;106:1524-7.
PubMed Text format Related articles Abstract available

SONG J , Li M, Zagaja GP, Taxy JB, et al
Intraoperative frozen section assessment of pelvic lymph nodes during radical prostatectomy is of limited value.
BJU Int. 2010;106:1463-7.
PubMed Text format Related articles Abstract available

October 2010

SANO F , Terao H, Kawahara T, Miyoshi Y, et al
Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer.
BJU Int. 2010 Oct 29. doi: 10.1111/j.1464-410X.2010.09735.
PubMed Text format Related articles Abstract available

RAYMUNDO EM , Rice KR, Chen Y, Zhao J, et al
Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system.
BJU Int. 2010 Oct 29. doi: 10.1111/j.1464-410X.2010.09685.
PubMed Text format Related articles Abstract available

MOTOFEI IG , Rowland DL, Popa F, Kreienkamp D, et al
Preliminary study with bicalutamide in heterosexual and homosexual patients with prostate cancer: a possible implication of androgens in male homosexual arousal.
BJU Int. 2010 Oct 18. doi: 10.1111/j.1464-410X.2010.09764.
PubMed Text format Related articles Abstract available

CHRISTENSSON A , Bruun L, Bjork T, Cronin AM, et al
Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.
BJU Int. 2010 Oct 18. doi: 10.1111/j.1464-410X.2010.09761.
PubMed Text format Related articles Abstract available

MARBERGER M , Wilson TH, Rittmaster RS
Low serum testosterone levels are poor predictors of sexual dysfunction.
BJU Int. 2010 Oct 18. doi: 10.1111/j.1464-410X.2010.09766.
PubMed Text format Related articles Abstract available

WADHWA VK , Weston R, Parr NJ
Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer.
BJU Int. 2010 Oct 15. doi: 10.1111/j.1464-410X.2010.09726.
PubMed Text format Related articles Abstract available

CARLSSON SV , Holmberg E, Moss SM, Roobol MJ, et al
No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer.
BJU Int. 2010 Oct 15. doi: 10.1111/j.1464-410X.2010.09712.
PubMed Text format Related articles Abstract available

STEUBER T , Budaus L, Walz J, Zorn KC, et al
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
BJU Int. 2010 Oct 13. doi: 10.1111/j.1464-410X.2010.09730.
PubMed Text format Related articles Abstract available

FAITHFULL S , Cockle-Hearne J, Khoo V
Self-management after prostate cancer treatment: evaluating the feasibility of providing a cognitive and behavioural programme for lower urinary tract symptoms.
BJU Int. 2010 Oct 13. doi: 10.1111/j.1464-410X.2010.09588.
PubMed Text format Related articles Abstract available

GEORGE D
How does sipuleucel-T alter our clinical practice?
BJU Int. 2010;106:945-6.
PubMed Text format Related articles

CATTON C , Parker C, Saad F, Sydes M, et al
Prostate radiotherapy after radical prostatectomy: sooner or later?
BJU Int. 2010;106:946-8.
PubMed Text format Related articles

ARUMAINAYAGAM N , Kumaar S, Ahmed HU, Moore CM, et al
Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy.
BJU Int. 2010;106:991-7.
PubMed Text format Related articles Abstract available

O'BRIEN R , Rose PW, Campbell C, Weller D, et al
Experiences of follow-up after treatment in patients with prostate cancer: a qualitative study.
BJU Int. 2010;106:998-1003.
PubMed Text format Related articles Abstract available

EYMARD JC , Oudard S, Gravis G, Ferrero JM, et al
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study.
BJU Int. 2010;106:974-8.
PubMed Text format Related articles Abstract available

LEVY DA , Pisters LL, Jones JS
Prognostic value of initial prostate-specific antigen levels after salvage cryoablation for prostate cancer.
BJU Int. 2010;106:986-90.
PubMed Text format Related articles Abstract available

HAYES JH , Chen MH, Moran BJ, Braccioforte MH, et al
Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke.
BJU Int. 2010;106:979-85.
PubMed Text format Related articles Abstract available

MORICHETTI D , Mazzucchelli R, Stramazzotti D, Santinelli A, et al
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer.
BJU Int. 2010;106:1072-80.
PubMed Text format Related articles Abstract available

LE JD , Cooperberg MR, Sadetsky N, Hittelman AB, et al
Changes in specific domains of sexual function and sexual bother after radical prostatectomy.
BJU Int. 2010;106:1022-9.
PubMed Text format Related articles Abstract available

KORDAN Y , Barocas DA, Altamar HO, Clark PE, et al
Comparison of transfusion requirements between open and robotic-assisted laparoscopic radical prostatectomy.
BJU Int. 2010;106:1036-40.
PubMed Text format Related articles Abstract available

MCVEY GP , McPhail S, Fowler S, McIntosh G, et al
Initial management of low-risk localized prostate cancer in the UK: analysis of the British Association of Urological Surgeons Cancer Registry.
BJU Int. 2010;106:1161-4.
PubMed Text format Related articles Abstract available

CAIRE AA , Sun L, Polascik TJ, Albala DM, et al
Obese African-Americans with prostate cancer (T1c and a prostate-specific antigen, PSA, level of <10 ng/mL) have higher-risk pathological features and a greater risk of PSA recurrence than non-African-Americans.
BJU Int. 2010;106:1157-60.
PubMed Text format Related articles Abstract available

PARK KK , Lee SH, Lim BJ, Kim JH, et al
The effects of the period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer.
BJU Int. 2010;106:1148-51.
PubMed Text format Related articles Abstract available

GYOMBER D , Lawrentschuk N, Wong P, Parker F, et al
Improving informed consent for patients undergoing radical prostatectomy using multimedia techniques: a prospective randomized crossover study.
BJU Int. 2010;106:1152-6.
PubMed Text format Related articles Abstract available

BOLENZ C , Gupta A, Hotze T, Ho R, et al
The influence of body mass index on the cost of radical prostatectomy for prostate cancer.
BJU Int. 2010;106:1188-93.
PubMed Text format Related articles Abstract available

REMZI M , Haese A, Van Poppel H, De La Taille A, et al
Follow-up of men with an elevated PCA3 score and a negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer?
BJU Int. 2010;106:1138-42.
PubMed Text format Related articles Abstract available

PLOUSSARD G , Haese A, Van Poppel H, Marberger M, et al
The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?
BJU Int. 2010;106:1143-7.
PubMed Text format Related articles Abstract available

September 2010

MUNDY AR , Andrich DE
Urorectal fistulae following the treatment of prostate cancer.
BJU Int. 2010 Sep 30. doi: 10.1111/j.1464-410X.2010.09686.
PubMed Text format Related articles Abstract available

WIEGAND LR , Hernandez M, Pisters LL, Spiess PE, et al
Surgical management of lymph-node-positive prostate cancer: improves symptomatic control.
BJU Int. 2010 Sep 29. doi: 10.1111/j.1464-410X.2010.09657.
PubMed Text format Related articles Abstract available

GILLITZER R , Thuroff C, Fandel T, Thomas C, et al
Intraoperative peripheral frozen sections do not significantly affect prognosis after nerve-sparing radical prostatectomy for prostate cancer.
BJU Int. 2010 Sep 29. doi: 10.1111/j.1464-410X.2010.09591.
PubMed Text format Related articles Abstract available

WALLNER LP , Morgenstern H, McGree ME, Jacobson DJ, et al
The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study.
BJU Int. 2010 Sep 29. doi: 10.1111/j.1464-410X.2010.09703.
PubMed Text format Related articles Abstract available

WALZ J , Joniau S, Chun FK, Isbarn H, et al
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.
BJU Int. 2010 Sep 28. doi: 10.1111/j.1464-410X.2010.09594.
PubMed Text format Related articles Abstract available

JOHANSSON A , Rudolfsson SH, Kilter S, Bergh A, et al
Targeting castration-induced tumour hypoxia enhances the acute effects of castration therapy in a rat prostate cancer model.
BJU Int. 2010 Sep 22. doi: 10.1111/j.1464-410X.2010.09690.
PubMed Text format Related articles Abstract available

KIM HS , Moreira DM, Smith MR, Presti JC Jr, et al
A natural history of weight change in men with prostate cancer on androgen-deprivation therapy (ADT): results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
BJU Int. 2010 Sep 22. doi: 10.1111/j.1464-410X.2010.09679.
PubMed Text format Related articles Abstract available

COEN JJ , Feldman AS, Smith MR, Zietman AL, et al
Watchful waiting for localized prostate cancer in the PSA era: what have been the triggers for intervention?
BJU Int. 2010 Sep 22. doi: 10.1111/j.1464-410X.2010.09652.
PubMed Text format Related articles Abstract available

PIERORAZIO PM , Humphreys E, Walsh PC, Partin AW, et al
Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenarians.
BJU Int. 2010;106:791-5.
PubMed Text format Related articles Abstract available

TEETER AE , Sun L, Moul JW, Freedland SJ, et al
External validation of the SEARCH model for predicting aggressive recurrence after radical prostatectomy: results from the Duke Prostate Center Database.
BJU Int. 2010;106:796-800.
PubMed Text format Related articles Abstract available

LANGLEY R , Price P, Pollock P, Abel PD, et al
Osteoporosis in patients with prostate cancer on long-term androgen deprivation therapy: an increasing but under-recognised problem.
BJU Int. 2010;106:726-7.
PubMed Text format Related articles

PATEL VR , Coelho RF, Chauhan S, Orvieto MA, et al
Continence, potency and oncological outcomes after robotic-assisted radical prostatectomy: early trifecta results of a high-volume surgeon.
BJU Int. 2010;106:696-702.
PubMed Text format Related articles Abstract available

KATZ MS , Carroll PR, Cowan JE, Chan JM, et al
Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: results from CaPSURE.
BJU Int. 2010;106:627-32.
PubMed Text format Related articles Abstract available

MATIKAINEN MP , von Bodman CJ, Secin FP, Yunis LH, et al
The depth of the prostatic apex is an independent predictor of positive apical margins at radical prostatectomy.
BJU Int. 2010;106:622-6.
PubMed Text format Related articles Abstract available

POULSEN MH , Bouchelouche K, Gerke O, Petersen H, et al
[18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.
BJU Int. 2010;106:639-43.
PubMed Text format Related articles Abstract available

August 2010

DUBBELMAN Y , Groen J, Wildhagen M, Rikken B, et al
The recovery of urinary continence after radical retropubic prostatectomy: a randomized trial comparing the effect of physiotherapist-guided pelvic floor muscle exercises with guidance by an instruction folder only.
BJU Int. 2010;106:515-22.
PubMed Text format Related articles Abstract available

TEWARI AK , Patel ND, Leung RA, Yadav R, et al
Visual cues as a surrogate for tactile feedback during robotic-assisted laparoscopic prostatectomy: posterolateral margin rates in 1340 consecutive patients.
BJU Int. 2010;106:528-36.
PubMed Text format Related articles Abstract available

GRECO F , Wagner S, Hoda MR, Kawan F, et al
Laparoscopic vs open retropubic intrafascial nerve-sparing radical prostatectomy: surgical and functional outcomes in 300 patients.
BJU Int. 2010;106:543-7.
PubMed Text format Related articles Abstract available

June 2010

HAN M , Trock BJ, Partin AW, Humphreys EB, et al
The impact of preoperative erectile dysfunction on survival after radical prostatectomy.
BJU Int. 2010.
PubMed Text format Related articles Abstract available

January 2010

KWON T , Jeong IG, You D, Park MC, et al
Effect of prostate size on pathological outcome and biochemical recurrence after radical prostatectomy for prostate cancer: is it correlated with serum testosterone level?
BJU Int. 2010.
PubMed Text format Related articles Abstract available

April 2009

HULL D , Ma J, Singh H, Hossain D, et al
Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases.
BJU Int. 2009.
PubMed Text format Related articles Abstract available

March 2009

PATEL SG , Cookson MS, Barocas DA, Clark PE, et al
Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
BJU Int. 2009.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.
Design: